BlackRock Advisors’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $1.14M | Sell |
35,623
-3,378
| -9% | -$108K | ﹤0.01% | 1738 |
|
|
2016
Q3 | $1.95M | Buy |
39,001
+25,346
| +186% | +$1.27M | ﹤0.01% | 1435 |
|
|
2016
Q2 | $579K | Sell |
13,655
-670
| -5% | -$28.4K | ﹤0.01% | 2003 |
|
|
2016
Q1 | $944K | Sell |
14,325
-16,629
| -54% | -$1.1M | ﹤0.01% | 1727 |
|
|
2015
Q4 | $1.92M | Buy |
30,954
+2,679
| +9% | +$167K | ﹤0.01% | 1403 |
|
|
2015
Q3 | $1.89M | Sell |
28,275
-898
| -3% | -$60.1K | ﹤0.01% | 1363 |
|
|
2015
Q2 | $2.84M | Sell |
29,173
-13,597
| -32% | -$1.32M | ﹤0.01% | 1115 |
|
|
2015
Q1 | $4M | Sell |
42,770
-937
| -2% | -$87.6K | ﹤0.01% | 996 |
|
|
2014
Q4 | $3.89M | Buy |
43,707
+18,050
| +70% | +$1.6M | ﹤0.01% | 1015 |
|
|
2014
Q3 | $1.77M | Buy |
25,657
+20,365
| +385% | +$1.41M | ﹤0.01% | 1181 |
|
|
2014
Q2 | $304K | Sell |
5,292
-1,135
| -18% | -$65.2K | ﹤0.01% | 2347 |
|
|
2014
Q1 | $255K | Buy |
6,427
+308
| +5% | +$12.2K | ﹤0.01% | 2488 |
|
|
2013
Q4 | $257K | Buy |
6,119
+487
| +9% | +$20.5K | ﹤0.01% | 2484 |
|
|
2013
Q3 | $168K | Buy |
5,632
+254
| +5% | +$7.58K | ﹤0.01% | 2649 |
|
|
2013
Q2 | $285K | Buy |
+5,378
| New | +$285K | ﹤0.01% | 2236 |
|